Work

Weekly Temsirolimus and Bortezomib For Relapsed Or Refractory B-Cell Non-Hodgkin Lymphoma: A Wisconsin Oncology Network Phase II Study

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.3035.3035

Authors: Timothy S. Fenske, KyungMann Kim, Chong Zhang, John P. Farnen, Adedayo A. Onitilo, Jules H. Blank, Harish Ahuja, Tim Wassenaar, Rubina Qamar, Patrick Mansky, Anne Traynor, Ryan J. Mattison, Brad S. Kahl

Institutions: Medical College of Wisconsin, University of Wisconsin–Madison, Gundersen Health System, Gundersen Lutheran Hospital, Marshfield Clinic, St. Vincent Hospital, Aspirus, Aspirus Wausau Hospital, ProHealth Care, Aurora Health Care, Bellin Memorial Hospital, University of Wisconsin Carbone Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W767219806

FWCI: 0.223

Cites:

Cited by: 1

Related to: 10